Kala Pharmaceuticals Inc. News
Kala Pharma Tumbles Despite FDA Approval of Dry Eye Drug
Kala Pharmaceuticals slides even after the FDA approves its dry-eye disease treatment.
Kala Pharmaceuticals Joins NASDAQ, the Biotech IPOs Keep Coming
After offering six million shares, the stock was up 18% to $17.70.
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Ransomware Suspect Charged in U.S. as Incidents Surge
A Russian citizen is charged in the U.S. for his alleged role in an international cryptocurrency money laundering conspiracy.
TheStreet's Doug Kass: Don't Be Fooled by Stock Rally
The S&P 500 index has jumped 11% in the past month, 'reducing the general attraction of equities,' investor Doug Kass says.